As the world continues to face diabetes burden, accurate and efficient glucose monitoring becomes paramount for managing this condition. Courtesy of this, global demand for glucose monitoring devices is anticipated to surge at 10.6% CAGR during the next decade.
According to Future Market Insights’ updated report, the global market value is projected to increase from US$ 16.2 billion in 2024 to US$ 44.6 billion by 2034. The market was valued at US$ 14.7 billion at the end of 2023 and is set to exhibit a y-o-y growth of 10.3% in 2024.
A spike in diabetes cases globally is set to create a conducive environment for the development of the blood sugar monitoring device market. Diabetes is estimated to affect around 643 million people in 2030 and 783 million by 2045, according to the International Diabetes Federation (IDF).
As the prevalence of diabetes will rise, so will the requirement for constant monitoring of blood sugar levels. This, in turn, is anticipated to propel demand for blood sugar monitoring devices during the assessment period.
A key trend observed in the market is the shift towards continuous glucose monitoring devices. This is because these devices offer more real-time data than traditional glucose monitoring tools. To capitalize on this trend, key players are looking to develop less invasive, user-friendly, and multifunctional continuous glucose monitoring systems.
Governments across the world are striving for the prevention and management of diabetes. For instance, new awareness campaigns are being launched. This will also play a key role in boosting market growth.
Another key factor propelling sales growth is the growing popularity of point-of-care testing (POCT) devices in diabetes management. Similarly, ongoing innovation in glucose monitoring systems will benefit the market.
Global Glucose Monitoring Device Market Forecast
| Attributes | Key Insights |
|---|---|
| Market Value in 2023 | US$ 14.7 billion |
| Market Revenue in 2024 | US$ 16.2 billion |
| Global Glucose Monitoring Device Market Size in 2034 | US$ 44.6 billion |
| Value CAGR (2024 to 2034) | 10.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The glucose monitoring device industry is experiencing robust growth due to investment in research and development (R&D) efforts. These efforts are aimed at propelling advances in device technologies such as wearable sensors, cloud-based platforms, and smartphone integration. They are aimed at pushing the boundaries of innovation within the field.
Advances in sensor technologies and AI integration are boosting the glucose monitoring product market. Sensor technologies are becoming increasingly smaller, allowing for more discreet and comfortable wear. Miniaturization also enables the integration of sensors into wearable devices, such as smartwatches and patches.
Patients, healthcare providers, and other stakeholders are increasingly seeking devices that offer improved accuracy, reliability, and usability. Manufacturers are responding to this demand by investing heavily in research and development to bring innovative products to market. As a result, we are witnessing a rapid evolution in the capabilities of blood sugar monitoring devices, with each new generation offering enhanced features and performance.
By pushing the boundaries of technology and innovation, key manufacturers in the market are propelling positive change in the healthcare landscape and empowering patients to manage their health better. This will bode well for the target market during the next ten years.
The global glucose monitoring product industry recorded a CAGR of 9.1% from 2019 to 2023. In comparison, a robust CAGR of 10.6% has been estimated by Future Market Insights analysts for the target market between 2024 and 2034, indicating a spike of 1.5% from the historical growth rate.
Historically, in patients with type 1 and type 2 diabetes, self-monitoring of blood glucose (SMBG) became the standard of care. This advanced device, along with A1C testing and insulin pump therapy, created effortless diabetes management and testing issues, impacting business growth. The evolution of home glucose monitoring has further changed with the introduction of continuous glucose monitoring (CGM).
The CGM system represents a significant innovation in blood glucose monitoring technology. This device continuously measures glucose in liquid media, providing users with information on time and patterns. CGM can provide a deeper understanding of blood sugar changes and help patients and doctors optimize diabetes management strategies.
The blood sugar measuring device market, which was established based on the need to improve diabetes control and make it easier for patients, continues to develop with the development of technology. The integration of CGM, artificial intelligence, and monitoring technologies is anticipated to lead to further growth and innovation in diabetes management.
Principal Consultant
The integration of new features, such as longer usage time in continuous glucose monitoring (CGM), is a big advancement in the device. CGM systems allow users to monitor blood sugar levels continuously over a long period of time, providing rapid insights without the need for frequent changes. This not only increases consumer convenience but also improves compliance with blood sugar testing, leading to better outcomes in diabetes management.
Advances in sensor technology have brought significant opportunities to the blood glucose monitoring industry by improving accuracy and wear resistance. By constantly innovating and improving designs, products, and functions, manufacturers can meet the needs of people with diabetes and ultimately improve their lives and health.
The growth in telemedicine globally offers great opportunities for people with diabetes. Telemedicine involves the delivery of healthcare services remotely through communication technology, providing a convenient and accessible platform for patients with diabetes to receive medical treatment and care for their disease.
Telemedicine can also facilitate patient education and self-management by providing access to education, support groups, and behavioral therapy for people with diabetes. By combining telemedicine with blood sugar monitoring devices, patients can receive personalized advice, guidance and guidance to help them better understand their condition and make the most of it.
Advanced technologies can play a key role in revolutionizing diabetes management and enabling people to live healthy lives. They will create opportunities for the global glucose monitoring device industry through 2034.
The high cost of glucose monitoring products is a major barrier to their adoption, especially in low- and middle-income countries. While these devices offer advanced technology and new features that can benefit people with diabetes, their high costs often prevent them from being available to those in need.
In many regions where healthcare infrastructure is limited and economic poverty is common, the cost of purchasing this equipment puts it beyond the reach of the majority of the population. The availability of traditional blood glucose monitoring methods, such as urine collection and blood tests, has also become a barrier to the use of blood sugar monitoring devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below shows the future growth rates of the top countries. India and China are set to record high CAGRs of 17.6% and 16.6%, respectively, through 2034. This can be attributed to high prevalence of diabetes due to urbanization, growing geriatric population, reduced levels of physical activity, and bad eating habits.
Market Growth Outlook by Key Countries
| Countries | Value CAGR |
|---|---|
| United States | 6.1% |
| China | 16.6% |
| Japan | 4.0% |
| Germany | 6.7% |
| India | 17.6% |
The United States glucose monitoring device market is set to be valued at US$ 4,910.2 million in 2024 and is going forward with a stable CAGR of 6.1% throughout the forecast period. Growing incidence of diabetes, favorable government initiatives, and availability of advanced medical technologies are key factors spearheading this growth.
In recent years, there has been a spike in cases of prediabetes and diabetes in the United States. For instance, according to the Centers for Disease Control and Prevention (CDC), over 37.3 million people in the United States have diabetes. This will continue to create demand for glucose monitoring devices to manage the condition effectively.
Increased awareness of diabetes management, thanks to campaigns such as the American Diabetes Association's "Count Me" campaign, is calling for action. The use of blood glucose monitoring products continues to increase in the region as awareness grows and the importance of monitoring becomes clear, allowing people to better manage their condition and improve their consumption with full health.
The United States is also home to several leading glucose-monitoring device manufacturers who are striving to develop novel solutions. This will further boost market growth during the assessment period.
China is becoming a hotbed for manufacturers owing to high patient pool, favorable government support, and escalating health awareness. As per the latest report, China market is poised to grow rapidly, with sales of glucose monitoring devices surging at 16.6% CAGR.
The glucose measurement industry in China has invested heavily in research and development (R&D) to promote the advancement of technology. These investments are significant and aim to push the boundaries of innovation in this field. One area of focus is the development of sensor technology.
Patients, doctors, and other stakeholders are increasingly looking for devices that provide greater accuracy, reliability, and usability. As a result, the Chinese market has seen rapid growth in the capacity of blood glucose meters, with each new generation of equipment providing better performance and performance.
Japan is anticipated to record a CAGR of 4.0% during the next decade. This is attributed to surging geriatric population, advances in glucose monitoring systems, and escalating popularity of home healthcare.
The blood sugar monitoring device market in Japan is also receiving a significant boost due to manufacturers offering insurance facilities for such devices. Several Japan-based companies are striving to make diabetes monitoring and management accessible to general public.
Notably, Terumo Corporation, a prominent player in the industry, announced on December 1, 2022, that reimbursement coverage within the Japanese medical insurance system has been extended for the Dexcom G6 CGM System. This development signifies a pivotal step forward in improving access to advanced continuous glucose monitoring technology for individuals managing diabetes in Japan.
The section below throws some light on top revenue-generation segments and their future growth rates. Companies can use this information to invest in popular products to stay ahead of the global market.
By product, self-monitoring devices currently dominate the market with a share of 57.9%, while the continuous monitoring devices segment is poised to record a CAGR of 14.7% through 2034. Based on indication, the diabetes type II segment will hold a market share of 72.4% in 2024 and further grow at 12.3% CAGR during the projection period.
Market Growth Outlook by Key Product
| Product | Value CAGR |
|---|---|
| Continuous Monitoring Devices | 14.7% |
| Self-monitoring Devices | 6.7% |
As per the latest analysis, self-monitoring devices dominate the global market with a value share of 57.9% in 2024 and their demand is set to rise at 6.7% CAGR through 2034. This is attributable to their convenience, affordability, and other advantages.
Self-monitoring devices, such as test strips and glucometers, are convenient to use and are available at low costs compared to continuous glucose monitoring systems. As a result, they have become more accessible to a wide range of patients.
On the other hand, sales of continuous glucose monitoring devices are poised to rise at a higher CAGR of 14.7% through 2034. This is due to their capability to offer real-time data than traditional glucose monitoring products, thereby allowing for better diabetes management.
Technological advances in continuous glucose monitoring technology are making them user-friendly and more affordable. This, in turn, will encourage their adoption of diabetes monitoring and management, resulting in the target segment overtaking the self-monitoring one.
Market Growth Outlook by Key Indication
| Indication | Value CAGR |
|---|---|
| Diabetes Type I | 6.2% |
| Diabetes Type II | 12.3% |
| Gestational Diabetes | 2.7% |
The diabetes II segment will retain its market dominance throughout the forecast period, accounting for a share of 72.4% in 2024. It is projected to advance at 12.3% CAGR between 2024 and 2034.
High prevalence of diabetes type II is a prominent factor behind the success of the target segment. According to the International Diabetes Federation (IDF), more than 90% of people with diabetes have type 2 diabetes, resulting in higher demand for glucose monitoring products to manage this condition.
Diabetes is a global concern that is increasing the healthcare spending by individuals to tackle the disease on an earlier basis. This high spending includes the treatment and diagnosis processes using glucose monitoring products and other tools.
Given the high prevalence and economic impact of type 2 diabetes, there is a pressing need for comprehensive strategies aimed at curbing its progression and reducing associated healthcare expenditures. This, in turn, is positively impacting glucose monitoring device sales.
In the constantly evolving glucose monitoring device industry, several opportunities exist. In order to capitalize, key companies are innovating to develop novel glucose measuring and monitoring solutions. For instance, some companies are looking to develop apps that connect to glucose monitoring solutions for remote and continuous glucose monitoring.
New product launches and approvals are gaining popularity in the market. Similarly, players are implementing strategies like mergers, partnerships, distribution agreements, collaborations, and acquisitions to boost their sales and stay ahead of the competition.
Recent Developments in Glucose Monitoring Product Market
The global market is estimated to be valued at US$ 16.2 billion in 2024.
Global sales are projected to soar at 10.6% CAGR through 2034.
By 2034, the global market size is forecast to reach US$ 44.6 billion.
The United States, China, Japan, Germany, and India.
From 2019 to 2023, the target market grew at a CAGR of 9.1%.
The global glucose sensor market size is set to reach US$ 16,382 million by 2032.
India’s market size is projected to reach US$ 905.4 million in 2024.
The global continuous glucose monitoring system market is poised to grow at 25.1% CAGR.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Value-Added Insights
4.1. Disease Epidemiology, By Key Regions
4.1.1. Rate Undiagnosed Diabetes
4.1.2. Age and Gender Specific Diabetes Cases
4.2. Product Adoption Analysis
4.3. Recent Product Launches
4.4. Regulatory Landscape
4.4.1. Regulatory Frameworks in United States
4.4.2. Regulatory Frameworks in Canada
4.4.3. Regulatory Frameworks in Europe
4.4.4. Regulatory Frameworks in India
4.4.5. Regulatory Frameworks in China
4.4.6. Regulatory Frameworks in Australia
4.5. Reimbursement Scenario
4.6. PESTLE Analysis
4.7. Porters Analysis
4.8. Supply Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure
5.1.2. R&D Funding Outlook, By Region
5.1.3. R&D Funding Outlook, By Country
5.1.4. Global Diabetic Care Device Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historic Growth
5.2.2. Increasing Diabetes Cases
5.2.3. Rising Awareness and Healthcare Expenditure
5.2.4. Increasing Incidence of Gestational Diabetes
5.2.5. High Cost of Devices
5.2.6. Continuous Advancements in Glucose Monitoring Technology
5.2.7. Growing Emphasis on Self-Monitoring
5.2.8. Government Initiatives and Reimbursement Policies
5.2.9. Integration with Smart Devices and Digital Health
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand Volume (Thousand Units) & Value Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Volume (Units) Analysis, 2019 to 2023
6.2. Current and Future Market Volume (Units) Projections, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Assessment
7.1. Global Pricing Analysis By Products and Region
7.2. Pricing Assumptions
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ billion) & Volume (Units) Analysis By Product, 2019 to 2023
8.3. Current and Future Market Size (US$ billion) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034
8.3.1. Continuous Monitoring Devices
8.3.1.1. Monitors
8.3.1.2. Sensors
8.3.1.3. Transmitters
8.3.2. Self-monitoring Devices
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ billion) Analysis, By Indication, 2019 to 2023
9.3. Current and Future Market Size (US$ billion) Analysis and Forecast By Indication, 2024 to 2034
9.3.1. Diabetes Type I
9.3.2. Diabetes Type II
9.3.3. Gestational Diabetes
9.4. Market Attractiveness Analysis By Indication
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ billion), By End User, 2019 to 2023
10.3. Current and Future Market Size (US$ billion) and Forecast By End User, 2024 to 2034
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Home Care Settings
10.4. Market Attractiveness Analysis By End User
11. Global Market: Cross Sectional Analysis - Product Vs Indication
11.1. Historical Market Size (US$ billion) By Product Vs End User, 2019 to 2023
11.2. Current and Future Market Size (US$ billion) Analysis and Forecast by Product Vs Indication, 2024 to 2034
11.2.1. Continuous Monitoring Devices
11.2.1.1. Diabetes Type I
11.2.1.2. Diabetes Type II
11.2.1.3. Gestational Diabetes
11.2.2. Self-Monitoring Devices
11.2.2.1. Diabetes Type I
11.2.2.2. Diabetes Type II
11.2.2.3. Gestational Diabetes
12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ billion) & Volume (Units) Analysis by Region, 2019 to 2023
12.3. Current and Future Market Size (US$ billion) & Volume (Units) Analysis and Forecast by Region, 2024 to 2034
12.3.1. North America
12.3.2. Latin America
12.3.3. East Asia
12.3.4. South Asia & Pacific
12.3.5. Western Europe
12.3.6. Eastern Europe
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis by Region
13. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ billion) Analysis by Market Taxonomy, 2019 to 2023
13.3. Current and Future Market Size (US$ billion) Analysis and Forecast by Market Taxonomy, 2024 to 2034
13.3.1. By Country
13.3.1.1. United States
13.3.1.2. Canada
13.3.1.3. Mexico
13.3.2. By Product
13.3.3. By Indication
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Indication
13.4.4. By End User
13.5. Drivers & Restraints Impact Analysis
13.6. Country-Wise Analysis
13.6.1. United States Market Analysis
13.6.1.1. Introduction
13.6.1.2. Market Analysis and Forecast by Market Taxonomy
13.6.1.2.1. By Product
13.6.1.2.2. By Indication
13.6.1.2.3. By End User
13.6.2. Canada Market Analysis
13.6.2.1. Introduction
13.6.2.2. Market Analysis and Forecast by Market Taxonomy
13.6.2.2.1. By Product
13.6.2.2.2. By Indication
13.6.2.2.3. By End User
13.6.3. Mexico Market Analysis
13.6.3.1. Introduction
13.6.3.2. Market Analysis and Forecast by Market Taxonomy
13.6.3.2.1. By Product
13.6.3.2.2. By Indication
13.6.3.2.3. By End User
14. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ billion) Analysis by Market Taxonomy, 2019 to 2023
14.3. Current and Future Market Size (US$ billion) Analysis and Forecast by Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Chile
14.3.1.3. Rest of Latin America
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Indication
14.4.4. By End User
14.5. Drivers & Restraints Impact Analysis
14.6. Country-Wise Analysis
14.6.1. Brazil Market Analysis
14.6.1.1. Introduction
14.6.1.2. Market Analysis and Forecast by Market Taxonomy
14.6.1.2.1. By Product
14.6.1.2.2. By Indication
14.6.1.2.3. By End User
14.6.2. Chile Market Analysis
14.6.2.1. Introduction
14.6.2.2. Market Analysis and Forecast by Market Taxonomy
14.6.2.2.1. By Product
14.6.2.2.2. By Indication
14.6.2.2.3. By End User
15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ billion) Analysis by Market Taxonomy, 2019 to 2023
15.3. Current and Future Market Size (US$ billion) Analysis and Forecast by Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Indication
15.4.4. By End User
15.5. Drivers & Restraints Impact Analysis
15.6. Country-Wise Analysis
15.6.1. China Market Analysis
15.6.1.1. Introduction
15.6.1.2. Market Analysis and Forecast by Market Taxonomy
15.6.1.2.1. By Product
15.6.1.2.2. By Indication
15.6.1.2.3. By End User
15.6.2. Japan Market Analysis
15.6.2.1. Introduction
15.6.2.2. Market Analysis and Forecast by Market Taxonomy
15.6.2.2.1. By Product
15.6.2.2.2. By Indication
15.6.2.2.3. By End User
15.6.3. South Korea Market Analysis
15.6.3.1. Introduction
15.6.3.2. Market Analysis and Forecast by Market Taxonomy
15.6.3.2.1. By Product
15.6.3.2.2. By Indication
15.6.3.2.3. By End User
16. South Asia & Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ billion) Analysis by Market Taxonomy, 2019 to 2023
16.3. Current and Future Market Size (US$ billion) Analysis and Forecast by Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. India
16.3.1.2. ASEAN Countries
16.3.1.3. Australia & New Zealand
16.3.1.4. Rest of South Asia
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Indication
16.4.4. By End User
16.5. Drivers & Restraints Impact Analysis
16.6. Country-Wise Analysis
16.6.1. India Market Analysis
16.6.1.1. Introduction
16.6.1.2. Market Analysis and Forecast by Market Taxonomy
16.6.1.2.1. By Product
16.6.1.2.2. By Indication
16.6.1.2.3. By End User
16.6.2. ASEAN Countries Market Analysis
16.6.2.1. Introduction
16.6.2.2. Market Analysis and Forecast by Market Taxonomy
16.6.2.2.1. By Product
16.6.2.2.2. By Indication
16.6.2.2.3. By End User
16.6.3. Australia & New Zealand Market Analysis
16.6.3.1. Introduction
16.6.3.2. Market Analysis and Forecast by Market Taxonomy
16.6.3.2.1. By Product
16.6.3.2.2. By Indication
16.6.3.2.3. By End User
17. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ billion) Analysis by Market Taxonomy, 2019 to 2023
17.3. Current and Future Market Size (US$ billion) Analysis and Forecast by Market Taxonomy, 2024 to 2034
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. France
17.3.1.3. Spain
17.3.1.4. Italy
17.3.1.5. BENELUX
17.3.1.6. Nordic Countries
17.3.1.7. United Kingdom
17.3.1.8. Rest of Western Europe
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Indication
17.4.4. By End User
17.5. Drivers & Restraints Impact Analysis
17.6. Country-Wise Analysis
17.6.1. Germany Market Analysis
17.6.1.1. Introduction
17.6.1.2. Market Analysis and Forecast by Market Taxonomy
17.6.1.2.1. By Product
17.6.1.2.2. By Indication
17.6.1.2.3. By End User
17.6.2. France Market Analysis
17.6.2.1. Introduction
17.6.2.2. Market Analysis and Forecast by Market Taxonomy
17.6.2.2.1. By Product
17.6.2.2.2. By Indication
17.6.2.2.3. By End User
17.6.3. Spain Market Analysis
17.6.3.1. Introduction
17.6.3.2. Market Analysis and Forecast by Market Taxonomy
17.6.3.2.1. By Product
17.6.3.2.2. By Indication
17.6.3.2.3. By End User
17.6.4. Italy Republic Market Analysis
17.6.4.1. Introduction
17.6.4.2. Market Analysis and Forecast by Market Taxonomy
17.6.4.2.1. By Product
17.6.4.2.2. By Indication
17.6.4.2.3. By End User
17.6.5. BENELUX Republic Market Analysis
17.6.5.1. Introduction
17.6.5.2. Market Analysis and Forecast by Market Taxonomy
17.6.5.2.1. By Product
17.6.5.2.2. By Indication
17.6.5.2.3. By End User
17.6.6. Nordic Countries Market Analysis
17.6.6.1. Introduction
17.6.6.2. Market Analysis and Forecast by Market Taxonomy
17.6.6.2.1. By Product
17.6.6.2.2. By Indication
17.6.6.2.3. By End User
17.6.7. United Kingdom Market Analysis
17.6.7.1. Introduction
17.6.7.2. Market Analysis and Forecast by Market Taxonomy
17.6.7.2.1. By Product
17.6.7.2.2. By Indication
17.6.7.2.3. By End User
18. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.2. Historical Market Size (US$ billion) Analysis by Market Taxonomy, 2019 to 2023
18.3. Current and Future Market Size (US$ billion) Analysis and Forecast by Market Taxonomy, 2024 to 2034
18.3.1. By Country
18.3.1.1. Poland
18.3.1.2. Hungary
18.3.1.3. Russia
18.3.1.4. Rest of Eastern Europe
18.3.2. By Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Indication
18.4.4. By End User
18.5. Drivers & Restraints Impact Analysis
18.6. Country-Wise Analysis
18.6.1. Poland Market Analysis
18.6.1.1. Introduction
18.6.1.2. Market Analysis and Forecast by Market Taxonomy
18.6.1.2.1. By Product
18.6.1.2.2. By Indication
18.6.1.2.3. By End User
18.6.2. Hungary Market Analysis
18.6.2.1. Introduction
18.6.2.2. Market Analysis and Forecast by Market Taxonomy
18.6.2.2.1. By Product
18.6.2.2.2. By Indication
18.6.2.2.3. By End User
18.6.3. Russia Market Analysis
18.6.3.1. Introduction
18.6.3.2. Market Analysis and Forecast by Market Taxonomy
18.6.3.2.1. By Product
18.6.3.2.2. By Indication
18.6.3.2.3. By End User
19. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
19.1. Introduction
19.2. Historical Market Size (US$ billion) Analysis by Market Taxonomy, 2019 to 2023
19.3. Current and Future Market Size (US$ billion) Analysis and Forecast by Market Taxonomy, 2024 to 2034
19.3.1. By Country
19.3.1.1. Saudi Arabia
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. Other African Union
19.3.1.5. Rest of Middle East & Africa
19.3.2. By Product
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Indication
19.4.4. By End User
19.5. Drivers & Restraints Impact Analysis
19.6. Country-Wise Analysis
19.6.1. Saudi Arabia Market Analysis
19.6.1.1. Introduction
19.6.1.2. Market Analysis and Forecast by Market Taxonomy
19.6.1.2.1. By Product
19.6.1.2.2. By Indication
19.6.1.2.3. By End User
19.6.2. Türkiye Market Analysis
19.6.2.1. Introduction
19.6.2.2. Market Analysis and Forecast by Market Taxonomy
19.6.2.2.1. By Product
19.6.2.2.2. By Indication
19.6.2.2.3. By End User
19.6.3. South Africa Market Analysis
19.6.3.1. Introduction
19.6.3.2. Market Analysis and Forecast by Market Taxonomy
19.6.3.2.1. By Product
19.6.3.2.2. By Indication
19.6.3.2.3. By End User
19.6.4. Other African Union Market Analysis
19.6.4.1. Introduction
19.6.4.2. Market Analysis and Forecast by Market Taxonomy
19.6.4.2.1. By Product
19.6.4.2.2. By Indication
19.6.4.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Presence Analysis
20.3.1. Regional footprint of Players
20.3.2. Platform Type foot print by Players
20.3.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Branding and Promotional Strategies, By Key Manufactures
21.4. Competition Deep Dive
21.4.1. Abbott Laboratories
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Key Financials
21.4.1.4. SWOT Analysis
21.4.1.5. Key Developments
21.4.1.6. Sales Footprint
21.4.1.7. Strategy Overview
21.4.1.7.1. Marketing Strategy
21.4.1.7.2. Product Strategy
21.4.1.7.3. Channel Strategy
21.4.2. Dexcom, Inc.
21.4.3. F. Hoffmann-La Roche Ltd
21.4.4. Medtronic
21.4.5. LifeScan IP Holdings, LLC
21.4.6. Ascensia Diabetes Care Holdings AG.
21.4.7. ARKRAY, Inc.
21.4.8. ACON Laboratories, Inc.
21.4.9. NIPRO
21.4.10. Nova Biomedical
21.4.11. Ypsomed
21.4.12. Prodigy Diabetes Care, LLC.
21.4.13. ForaCare, Inc.
21.4.14. Trividia Health, Inc.
21.4.15. AgaMatrix
21.4.16. Beurer GmbH
21.4.17. All Medicus Co., Ltd.
21.4.18. HMD
21.4.19. Bioland Technology Limited.
21.4.20. OakTree-Health.com
21.4.21. Biosense Technologies Private Limited
21.4.22. Senseonics
21.4.23. Medtrum Technologies Inc.
21.4.24. Taidoc Technology Corporation
21.4.25. B. Braun SE
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Glucose Monitoring Device Market
